Patents by Inventor Jugnu Jain

Jugnu Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATING CANCER
    Publication number: 20220233624
    Abstract: The present invention is directed to methods of treating cancer and inhibiting proliferation of cancer cells with compositions comprising extracts prepared from Terminalia chebula fruits (for instance AyuFlex®), Terminalia bellerica fruits (for instance Ayuric®), Phyllanthus emblica fruits (for instance Capros®), Withania somnifera roots and leaves (for instance Sensoril®), Shilajit (for instance PrimaVie®), Azadirachta indica leaves and twigs (for instance PhytoBGS®), and/or combinations thereof, including a trivalent chromium complex with extracts of Shilajit and P. emblica (e.g. Crominex-3+®). Combinations of the extracts with anti-cancer drugs, and related methods, are also described.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 28, 2022
    Applicant: Natreon, Inc.
    Inventors: Sanyasi R. Kalidindi, Jugnu Jain, Bhawana Gupta
  • ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATING CANCER
    Publication number: 20210315959
    Abstract: The present invention is directed to methods of treating cancer and inhibiting proliferation of cancer cells with compositions comprising extracts prepared from Terminalia chebula fruits (for instance AyuFlex®), Terminalia bellerica fruits (for instance Ayuric®), Phyllanthus emblica fruits (for instance Capros®), Withania somnifera roots and leaves (for instance Sensoril®), Shilajit (for instance PrimaVie®), Azadirachta indica leaves and twigs (for instance PhytoBGS®), and/or combinations thereof, including a trivalent chromium complex with extracts of Shilajit and P. emblica (e.g. Crominex-3+®). Combinations of the extracts with anti-cancer drugs, and related methods, are also described.
    Type: Application
    Filed: March 4, 2021
    Publication date: October 14, 2021
    Applicant: Natreon, Inc.
    Inventors: Sanyasi R. Kalidindi, Jugnu Jain, Bhawana Gupta
  • Compositions comprising inhibitors of IMPDH enzyme
    Patent number: 7943593
    Abstract: The present invention relates to compositions comprising an apoptosis inducing anti-cancer agent and an IMPDH inhibitor. This invention also relates to methods for inducing apoptosis and for treating tumors and cancers in mammals.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: May 17, 2011
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Jugnu Jain-Pandey, Robert J. Fram
  • Biomarkers for Monitoring Impdh Pathway Inhibition
    Publication number: 20080318803
    Abstract: The present invention is directed to methods for ameliorating reproductive disorders. More specifically, the present invention describes methods and compositions for using IL-17 in the treatment of various infertility-related defects.
    Type: Application
    Filed: May 27, 2005
    Publication date: December 25, 2008
    Applicant: VERTEX PHARMACEUTICALS
    Inventors: Jugnu Jain, Matthew W. Harding, Ravi Ramachandran, Martyn Botfield
  • Compositions comprising inhibitors of IMPDH enzyme
    Publication number: 20050059734
    Abstract: The present invention relates to compositions comprising an apoptosis inducing anti-cancer agent and an IMPDH inhibitor. This invention also relates to methods for inducing apoptosis and for treating tumors and cancers in mammals.
    Type: Application
    Filed: December 4, 2003
    Publication date: March 17, 2005
    Inventors: Jugnu Jain-Pandey, Robert Fram
  • NF-AT.sub.p, ' a T lymphocyte DNA-binding protein
    Patent number: 5656452
    Abstract: Isolated nucleic acids encoding the NF-AT.sub.p protein, a T lymphocyte DNA binding protein.
    Type: Grant
    Filed: October 29, 1993
    Date of Patent: August 12, 1997
    Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Anjana Rao, Patrick Gerald Hogan, Patricia McCaffrey, Jugnu Jain